Beyond stigma: reframing antipsychotics as medical treatment
Antipsychotic non-adherence, driven partly by stigma, worsens outcomes in severe mental illness. Beyond ameliorating psychosis, evidence shows sustained antipsychotic treatment reduces mortality, cardiovascular risk, suicide, inflammation and cognitive decline, while improving quality of life. Reframing antipsychotics as essential medical care may reduce stigma and improve engagement with patients and clinicians.
Authors
- Xavier Boland (ORCID: https://orcid.org/0000-0002-2755-173X)
- Luiz Dratcu (ORCID: https://orcid.org/0000-0002-5888-4991)
Institutions
- South London and Maudsley NHS Foundation Trust (GB)
- Camden and Islington NHS Foundation Trust (GB)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2026-09-14
- DOI
- https://doi.org/10.1192/bjp.2026.10786
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00